Zdrowie i gospodarka · 01/09/1999

FDA Amends Delegations of Authority to Center for Biologics Evaluation and Research

The FDA is updating its authority structure to allow the Director and Deputy Directors of the CBER to issue license suspension notifications, a change intended to reflect recent redelegations of authority.